|
![](https://webarchive.library.unt.edu/eot2008/20090813063954im_/http://drugabuse.gov/images/spacer.gif)
Each year after getting our budget appropriation from Congress, NIDA establishes a funding plan implementing the NIH cost management guidelines in making research project grant awards. Below is a summary of the plan for FY 2006.
New and Renewal Research Project Grants (RPGs)
- Payline for RPGs is expected to be about the 15th percentile.
- In accordance with NIH policy new and renewal grants in aggregate will maintain the same average cost as FY 2005.
- Based on an analysis of available dollars and the number of highly competitive applications eligible for funding, NIDA expects that competing new and renewal awards will need to be reduced by an average of 10% to 15% from their requested budget level.
- In accordance with NIDA Guidelines for Funding of Competitive Renewal Grants, renewal grants should not increase by more than 10% over the previous year funding.
Noncompeting RPGs
- Consistent with NIH policy, all RPG continuation (R01,R03, R21, R33, R34, R36, R37, P01, U01, U19) will be reduced by -2.35% from the amount indicated in the Notice of Grant Award for the FY 2006 budget period. The amounts for any and all future year budget periods will also be reduced by the -2.35%.
Center Grants
- All center grant continuations (P20, P30, P50, U54) will also be reduced by -2.35% from the amount indicated in the Notice of Grant Award for the FY 2006 budget period. The amounts for any and all future year budget periods will also be reduced by the -2.35%.
|
|
|